AARD

NASDAQ 已收盘

Aardvark Therapeutics, Inc.

7.23 USD
+0.48+2.12%
盘后 6.94 -1.98%
2026-08-03
市值
$157.73M
市盈率
EPS
-3.21
股息率
52 周区间
3.35 – 17.94
成交量
131.98K
Beta
目标价
14.50
52W 低 3.3552W 高 17.94
价格走势

公司简介

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.